Market revenue in 2023 | USD 9,268.8 million |
Market revenue in 2030 | USD 16,031.2 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.99% in 2023. Horizon Databook has segmented the Japan healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
One of the key drivers of Japan’s healthcare CDMO market in Japan is its growing pharmaceutical industry. Other key drivers include rapid technological advancements and high healthcare expenditure. Japan is expected to show lucrative growth during the forecast period, owing to the rise in demand for new and cost-effective medical devices.
Presence of a stringent regulatory framework and high standards for medical device manufacturing are leading to an increase in overall costs, thus, increasing the need to maintain standards while reducing healthcare expenditure.
Furthermore, large number of CDMO collaborations, expansions, mergers & acquisitions, and other strategic initiatives undertaken by market players operating in the country are anticipated to boost the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Japan healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account